Tranylcypromine is a monoamine oxidase inhibitor (MAOI) antidepressant indicated for the treatment of major depressive disorder by preventing the enzymatic breakdown of key neurotransmitters, including… Read more















Tranylcypromine is a monoamine oxidase inhibitor (MAOI) antidepressant indicated for the treatment of major depressive disorder by preventing the enzymatic breakdown of key neurotransmitters, including serotonin, norepinephrine, and dopamine. Laboratories rely on high-quality reference standards of the active pharmaceutical ingredient, alongside its related impurities and metabolites, to ensure rigorous quality control and accurate impurity profiling. The use of stable isotope-labelled compounds, such as deuterium-labelled analogues, is essential for internal standardization in liquid chromatography-mass spectrometry (LC-MS) assays. These materials provide the necessary analytical tools for method validation and the reliable identification of potential degradation products or synthesis-related impurities. By incorporating these well-characterized reference materials, researchers can maintain the integrity of pharmaceutical testing and ensure compliance with regulatory standards throughout the drug development lifecycle.